You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma celebrates Primary Immunodeficiency Week

The company stands alongside PI patients associations around the globe

read more 

EVENTS

Kedrion Biopharma celebrates World Hemophilia Day 2018

Support for patients with coagulation disorders worldwide is confirmed

read more 

EVENTS

50-Year Anniversary of a Maternal Health Breakthrough

Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

read more 
  1. CORPORATE - 17-10-2014

    Kedrion announces more factual, long-term role in Africa

    The company’s efforts try to grant African patients better access to treatments

    read more 
  2. PLASMA & BIOTHERAPIES - 16-10-2014

    Investigating inhibitor development in patients with Hemophilia A

    Lecture on state-of-the-art of the SIPPET Study presented by P.M. Mannucci, sponsored by Grifols, Kedrion and LFB

    read more 
  3. EVENTS - 30-09-2014

    Festival della Salute: conference on self-sufficiency supported by Kedrion

    Plasma and plasma-derived products take centre stage at a workshop with all the stakeholders of the Italian Blood System

    read more 
  4. PLASMA & BIOTHERAPIES - 24-06-2014

    Counterfeit RhoGAM Ultra-Filtered PLUS used for preventing HDN found in India

    Johnson & Johnson Limited has identified counterfeit RhoGAM Ultra-Filtered PLUS in the state of West Bengal and Uttar Pradesh in India. This issue does not involve any other product manufactured or distributed by Ortho Clinical Diagnostics or Kedrion Biopharma India Pvt. Ltd.

    read more 

Pages

For more information please contact: pressoffice@kedrion.com